Obesity is linked to numerous health complications, including diabetes, cardiovascular disease, and fatty liver disease. In a ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Bill, 2025 relevant to the UPSC exam? What is the significance of topics such as the India's power shortage concerns, ...

A school-age child died of measles in Texas last month, and New Mexico reported its first measles-related death in an adult last week. Where else is measles showing up in the U.S.? Measles cases ...

Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Zealand Pharma's obesity drug candidate.

Mandal pointed out that the equal-weighted S&P 500 is nearly flat year ... US macroeconomic data has given mixed signals about the world's largest economy. The jobs report released last Friday ...

Retail spending across the US may have declined on a monthly basis last month as concerns over ... over-month decline and a 5.44 percent year-over-year increase recorded in January. “Consumer spending ...

Almost one third of households comprised of one adult and children under ... up a staggering 11 per cent compared to last year. Worryingly, this tells us that almost half of all one-parent ...

Allen's agent, Blake Baratz of Team IFA, told ESPN's Adam Schefter that the former Washington Commanders star agreed to a three-year contract worth $60 million. Minnesota then agreed to a five ...

Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from a late-stage study on next-generation obesity drug, CagriSema. Top-line ...

"We’re seeing less and less dip buying than we’ve seen in a while, which tells us people are stepping back ... Cash levels marched steadily higher last week, setting a fresh record of $7.3 ...